ALSC (Amyotrophic Lateral Sclerosis Consortium)

The Amyotrophic Lateral Sclerosis Consortium (ALSC) is a group dedicated to advancing research, understanding, and treatment of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease affecting motor neurons. ALS leads to muscle weakness, paralysis, and ultimately impacts daily living. The consortium brings together researchers, clinicians, and organizations to improve collaboration and share knowledge, aiming to accelerate the development of effective therapies and enhance patient care. By pooling resources and expertise, ALSC strives to make significant strides in combating this challenging disease and improving the lives of those affected by ALS.